Table 2.
Author and Year | Peer- Reviewed | Complete stat | Randomization | Blindness | Sample Size Calculation | Dose-Response Relation | Statement of Compliance with Regulatory | Objective Aligned with Analysis | Risk of Bias |
---|---|---|---|---|---|---|---|---|---|
Sadek et al., 2023 [52] | + | + | - | - | + | + | + | + | Low |
Bergamo et al., 2022 [53] | + | + | + | - | - | + | + | + | Low |
Britto et al., 2022 [54] | + | + | + | - | - | + | + | + | Low |
de Castro et al., 2022 [55] | + | + | + | - | - | + | + | + | Low |
Ellakany et al., 2022 [56] | + | + | + | - | + | + | + | + | Low |
Pantea et al., 2022 [57] | + | + | + | - | - | + | + | + | Low |
Simoneti et al., 2022 [58] | + | + | + | - | - | + | + | + | Low |
Tasin et al., 2022 [59] | + | + | - | - | + | + | + | + | Low |
Turksayar et al., 2022 [60] | + | + | - | - | + | + | + | + | Low |
Al-Qahtani et al., 2021 [61] | + | + | - | - | - | - | + | + | Moderate |
Mayer et al., 2021 [62] | + | + | - | - | - | + | + | + | Moderate |
Myagmar et al., 2021 [63] | + | + | + | - | - | + | + | + | Low |
Martín-Ortega et al., 2021 [64] | + | + | + | - | - | + | + | + | Low |
Park et al., 2020 [65] | + | + | - | - | - | + | - | + | Moderate |
Reeponmaha et al., 2020 [66] | + | + | + | - | + | + | + | + | Low |
Kessler et al., 2019 [67] | + | + | - | - | - | + | + | + | Low |
Park et al., 2018 [68] | + | + | - | - | - | + | + | + | Moderate |
Tahayeri et al., 2018 [69] | + | + | - | - | - | + | + | + | Low |
Digholkar el al, 2016 [70] | + | + | - | - | - | + | + | + | Moderate |
+: positive assessment of the item; -: negative assessment of the item.